🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Optic Neuropathy

Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis NCT06389968NA1 site📍 Munich Technical University of Munich · Tests: Light stimulation, Sham light stimulation Optic Nerve Injury in Obstructive Sleep Apnea Patients NCT06748703NA1 site📍 Nanjing Nanjing Medical University · Tests: CPAP Treatment Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies NCT07145073NA1 site📍 Taipei National Taiwan University Hospital · Tests: DC-Stimulator MC, DC-Stimulator MC Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma NCT05371977NA1 site📍 Helsinki Helsinki University Central Hospital · Tests: Trabeculectomy, Deep Sclerectomy Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects NCT03870230NA1 site📍 Vienna Medical University of Vienna · Tests: Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Dynamic Vessel Analyzer (DVA), Pattern Electroretinography… A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) NCT05199688Phase 314 sites📍 Denver📍 Ciudad Autonoma Buenos Aires📍 Córdoba Hoffmann-La Roche · Tests: Satralizumab Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. NCT06280755n/a3 sites📍 Prague📍 Bochum📍 Berlin icometrix Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases NCT06939166EARLY Phase 11 site📍 Tianjin Tianjin Huanhu Hospital · Tests: UCAR T-cell Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD NCT06885957n/a1 site📍 Wuhan Tongji Hospital · Tests: Mab Therapy Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844NA1 site📍 Liège Centre Hospitalier Universitaire de Liege · Tests: Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 sta… Dresden Glaucoma and Treatment Study (DGTS) NCT02959242n/a1 site📍 Dresden Technische Universität Dresden Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle) NCT06970106Phase 1, Phase 23 sites📍 Sydney📍 East Melbourne📍 Auckland PYC Therapeutics · Tests: PYC-001 Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) NCT07290244Phase 14 sites📍 Glendale📍 Boston📍 New York Life Biosciences Inc. · Tests: ER-100 epigenetic therapy Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) NCT06891443Phase 318 sites📍 San Francisco📍 Miami📍 Iowa City Laboratoires Thea · Tests: sepofarsen, Placebo IVT Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for NAION NCT05147701Phase 12 sites📍 Naples📍 Athens The Foundation for Orthopaedics and Regenerative Medicine · Tests: cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes A Longitudinal Natural History Study of OPA1-Associated Autosomal-Dominant Optic Atrophy NCT07729982n/a1 site📍 Munich Ludwig-Maximilians - University of Munich Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder NCT05549258Phase 219 sites📍 La Jolla📍 Loma Linda📍 Boston Amgen · Tests: Inebilizumab Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis NCT07206238n/a1 site📍 Glostrup Municipality Copenhagen University Hospital, Rigshospitalet · Tests: Positron Emission Tomography / Magnetic Resonance Imaging Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy NCT04451265n/a3 sites📍 Lille📍 Paris📍 Rouen Fondation Ophtalmologique Adolphe de Rothschild · Tests: MRI Metabolomics Analysis According to the Retinal Nerve Fiber Layer in Patients With NOHL Mutations (MétabOCT) NCT06682819NA1 site📍 Paris Hôpital Necker-Enfants Malades · Tests: Optical coherent tomography Inherited Retinal Degenerative Disease Registry NCT02435940n/a1 site📍 Columbia Foundation Fighting Blindness Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research NCT07623668Phase 34 sites📍 Livonia📍 Charleston📍 Dallas Oculis · Tests: Privosegtor, Methylprednisolone, Placebo A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage NCT07770685Phase 1, Phase 21 site📍 Boston Astellas Pharma Global Development, Inc. · Tests: ASP2767, Sham ASP2767, Prophylactic Regimen A, Prophylactic Regimen B, Placebo for prophylactic regimen Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD NCT06780709NA1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Wellness Program and Behavioral Counseling Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) NCT02521311Phase 21 site📍 San Francisco University of California, San Francisco · Tests: Clemastine, Placebo Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis NCT03401879NA1 site📍 Vienna Medical University of Vienna · Tests: Dynamic Vessel Analyzer (DVA), Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Optical coherence tomograph… Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study NCT07410039Phase 41 site📍 Beijing Chinese PLA General Hospital · Tests: Eculizumab+IVMP, IVIG+IVMP, IVMP Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases NCT00874783n/a1 site📍 Jerusalem Hadassah Medical Organization A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) NCT06413654Phase 2, Phase 351 sites📍 Beijing📍 Beijing📍 Beijing Shanghai Jiaolian Drug Research and Development Co., Ltd · Tests: B001, Placebo Edaravone in the Treatment of Optic Neuritis NCT05540262NA1 site📍 Nanning First Affiliated Hospital of Guangxi Medical University · Tests: Edaravone
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy